# Biomatics Capital

> Venture capital Gates-alumni che investe in genomica e digital health

## Executive Summary

| Metrica | Valore |
|---------|--------|
| **Fondazione** | 2016 |
| **Sede** | Seattle, USA |
| **Tipo** | PrivateEquity (Venture Capital) |
| **Leadership** | Boris Nikolic, Julie Sunderland (Managing Directors) |
| **Team** | 3 partner + associates |
| **AUM** | $500M (Fund I $200M + Fund II $300M) |
| **Status** | active |

---

## Glossario

| Termine | Definizione |
|---------|-------------|
| **Genomics** | Studio e applicazione del DNA per diagnostica e terapia |
| **Digital Health** | Tecnologie digitali applicate alla sanita' |
| **Unicorn** | Startup con valutazione >$1B |

---

## Fondazione e Storia

| Dato | Dettaglio |
|------|-----------|
| **Fondazione** | 2016 |
| **Fondatori** | [Boris Nikolic](../persons/boris-nikolic.md), [Julie Sunderland](../persons/julie-sunderland.md) |
| **Contesto** | Ex-advisor di Bill Gates lasciano Gates Foundation per creare VC indipendente |
| **Obiettivo dichiarato** | "Transforming health care and medicine, one investment at a time" |

### Background Fondatori

Nikolic e Sunderland hanno iniziato a investire insieme dal 2010, quando entrambi lavoravano per Bill Gates:
- **Nikolic**: Chief Advisor Science & Technology per Gates (2007-2015)
- **Sunderland**: Director Program Related Investments, Gates Foundation (2009-2016), gestendo portfolio $1.5B

### Timeline Storica

| Anno | Evento |
|------|--------|
| **2010** | Nikolic e Sunderland iniziano a co-investire |
| **2016** | Fondazione Biomatics Capital |
| **2017** | Chiusura Fund I a $200M |
| **2018** | Chiusura Fund II a $300M; apertura ufficio Boston |
| **2018** | Aggiunti Venture Partners Mike Poole (ex-Gates) e Errik Anderson |
| **2021** | Portfolio company Aledade diventa unicorn |
| **2024** | GRAIL IPO su NASDAQ |
| **2025** | Verve Therapeutics acquisita da Eli Lilly |

---

## Struttura e Governance

### Leadership

| Ruolo | Nome | Dal |
|-------|------|-----|
| Managing Director, Co-Founder | [Boris Nikolic](../persons/boris-nikolic.md) | 2016 |
| Managing Director, Co-Founder | [Julie Sunderland](../persons/julie-sunderland.md) | 2016 |
| Venture Partner | Mike Poole | 2018 |
| Venture Partner | Errik Anderson | 2018 |
| Business Operations Manager | Yeon Cramer | - |

### Fondi

| Fondo | Anno | Size | Target |
|-------|------|------|--------|
| Fund I | 2017 | $200M | 15-20 companies, $5-10M each |
| Fund II | 2018 | $300M | 15-20 companies, $5-30M each |

---

## Focus Investimenti

| Settore | Descrizione |
|---------|-------------|
| **Genomics** | DNA synthesis, gene editing, diagnostica genomica |
| **Digital Health** | Data-driven healthcare, telemedicina |
| **Therapeutics** | Biotech early-stage, neurologia, cardiovascolare |
| **Diagnostics** | Cancer screening, precision medicine |

### Stage

Primariamente **Series A e Series B**, con investimenti iniziali $5-10M e follow-on fino a $30M.

---

## Portfolio

### Exits Notevoli

| Azienda | Settore | Exit | Note |
|---------|---------|------|------|
| [GRAIL](../company/grail.md) | Cancer diagnostics | IPO NASDAQ 2024 | Backed by Gates, Bezos |
| [Aledade](../company/aledade.md) | Value-based care | Unicorn 2021 | $1B+ valuation |
| [Twist Bioscience](../company/twist-bioscience.md) | Synthetic DNA | IPO 2018 | - |
| [Verve Therapeutics](../company/verve-therapeutics.md) | Gene editing cardio | Acquired 2025 | Eli Lilly |

### Portfolio Attivo

| Azienda | Settore |
|---------|---------|
| [Denali Therapeutics](../company/denali-therapeutics.md) | Neurodegeneration |
| [eGenesis](../company/egenesis.md) | Xenotransplantation |
| Verana Health | Healthcare data |
| Omniome | DNA sequencing |
| Encodia | Proteomics |

### Metriche Portfolio

- **1 unicorn** (Aledade)
- **6 IPOs** (GRAIL, Twist, altri)
- **5 acquisizioni** (incl. Verve)

---

## Rete di Connessioni

### Mappa delle Relazioni

```
              BILL GATES
                  |
    +-------------+-------------+
    |                           |
    v                           v
BORIS NIKOLIC             JULIE SUNDERLAND
Chief Advisor 2007-15     Director PRI 2009-16
    |                           |
    +-------------+-------------+
                  |
                  v
          BIOMATICS CAPITAL
           (2016, $500M AUM)
                  |
    +------+------+------+------+
    |      |      |      |      |
    v      v      v      v      v
  GRAIL Aledade Twist  Verve  Denali
  (IPO) (unicorn)(IPO) (M&A)   ...
```

### Figure Chiave

| Persona | Ruolo |
|---------|-------|
| [Boris Nikolic](../persons/boris-nikolic.md) | Co-Founder, Managing Director |
| [Julie Sunderland](../persons/julie-sunderland.md) | Co-Founder, Managing Director |
| [Bill Gates](../persons/bill-gates.md) | Ex-employer di entrambi i fondatori |
| Mike Poole | Venture Partner (ex-Gates Foundation) |
| Errik Anderson | Venture Partner (Boston) |

### Co-Investitori Frequenti

| Fondo | Overlap |
|-------|---------|
| Arch Venture Partners | Multiple deals |
| Polaris Partners | Follow-on rounds |
| Lux Capital | Later stages |
| Casdin Capital | Life sciences |

### Connessioni Gates

| Persona | Background Gates |
|---------|------------------|
| Boris Nikolic | Chief Advisor Science & Tech |
| Julie Sunderland | Director PRI ($1.5B) |
| Mike Poole | Director Global Health Innovation |
| Yeon Cramer | Gates Ventures (6 anni) |

---

## Controversie

| Tema | Dettaglio |
|------|-----------|
| **Epstein connection** | Boris Nikolic nominato "successor executor" nel testamento di Jeffrey Epstein (2019). Nikolic dichiaro' di essere "shocked" e di non avere intenzione di accettare il ruolo. |

---

## Connessioni PowerLink

### Persone

| Persona | Relazione |
|---------|-----------|
| [Boris Nikolic](../persons/boris-nikolic.md) | Co-Founder |
| [Julie Sunderland](../persons/julie-sunderland.md) | Co-Founder |
| [Bill Gates](../persons/bill-gates.md) | Ex-employer, network |

### Organizzazioni

| Organizzazione | Relazione |
|----------------|-----------|
| [Gates Foundation](../foundation/gates-foundation.md) | Origine fondatori |
| [GRAIL](../company/grail.md) | Portfolio (IPO) |
| [Aledade](../company/aledade.md) | Portfolio (unicorn) |
| [Twist Bioscience](../company/twist-bioscience.md) | Portfolio (IPO) |
| [Verve Therapeutics](../company/verve-therapeutics.md) | Portfolio (acquired) |
| [Denali Therapeutics](../company/denali-therapeutics.md) | Portfolio |
| [eGenesis](../company/egenesis.md) | Portfolio |

---

## Fonti

### Ufficiali
- [Biomatics Capital - Homepage](https://biomaticscapital.com/)
- [Biomatics Capital - Team](https://biomaticscapital.com/team)

### Database
- [Crunchbase - Biomatics Capital](https://www.crunchbase.com/organization/biomatics-capital-partners)
- [PitchBook - Biomatics Capital](https://pitchbook.com/profiles/investor/151204-33)
- [Tracxn - Biomatics Capital](https://tracxn.com/d/venture-capital/biomatics-capital/__P9VJeQF2MuYVTDblkPJKifaEUuU8DI3-rM53jTx1Z_A)

### Notizie
- [TechCrunch - Gates' former advisors form $200M fund (Mar 2017)](https://techcrunch.com/2017/03/15/bill-gates-former-chief-science-advisor-has-formed-a-200m-fund-with-another-longtime-colleague/)
- [GeekWire - Biomatics raises $300M (Nov 2018)](https://www.geekwire.com/2018/biomatics-raises-300m-invest-health-startups-adds-gates-foundation-global-health-director/)
- [PRNewswire - Fund II announcement (Nov 2018)](https://www.prnewswire.com/news-releases/biomatics-capital-raises-300-million-for-second-healthcare-fund-expands-team-with-two-new-venture-partners-300745553.html)

### Epstein
- [Fox Business - Who is Boris Nikolic? (Aug 2019)](https://www.foxbusiness.com/features/who-is-boris-nikolic-epstein-executor)
- [Daily Beast - Boris Nikolic 'shocked' (Aug 2019)](https://www.thedailybeast.com/jeffrey-epsteins-will-leaves-dollar577-million-to-mysterious-trust/)

---

*Ultimo aggiornamento: Febbraio 2025*
